SPY749.60−0.63%QQQ674.25−0.83%BTC/USD65,518.60−3.98%DIA521.21−0.37%GLD355.70+0.07%TLT79.42+0.05%

Skye Bioscience Inc

SKYENASDAQ

Trade with Public

$1.09

0.010.93%

At close: Nov 13, 4:00 PM EST

$1.11

0.021.83%

After Hours: Nov 13, 9:22 AM EST

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Skye Bioscience (SKYE) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Skye Bioscience (SKYE) stock.

Analyst Consensus — 9 Analysts

2S.Buy

7Buy

# Analysts9

Latest Upgrades and Downgrades for Skye Bioscience Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	HC Wainwright & Co.	Ananda Ghosh	Initiate	Buy	$160
—	Evercore ISI Group	Michael DiFiore	Initiate	Outperform	$80
—	JMP Securities	Jonathan Wolleben	Maintained	Market Outperform	$120
—	Craig-Hallum	Albert Lowe	PT Cut	Buy	$144→$112
—	Citizens Capital Markets	Jonathan Wolleben	Maintained	Market Outperform	$120
—	William Blair	Andy Hsieh	Initiate	Outperform	—
—	Scotiabank	George Farmer	Initiate	Sector Outperform	$160
—	Piper Sandler	Edward Tenthoff	Maintained	Overweight	$160
—	Cantor Fitzgerald	Kristen Kluska	Maintained	Overweight	$112
—	JMP Securities	Jonathan Wolleben	Initiate	Market Outperform	$120
—	Cantor Fitzgerald	Kristen Kluska	Maintained	Overweight	$112
—	Cantor Fitzgerald	Kristen Kluska	Maintained	Overweight	$112
—	Cantor Fitzgerald	Kristen Kluska	Maintained	Overweight	$112
—	Craig-Hallum	Albert Lowe	Initiate	Buy	$144
—	Cantor Fitzgerald	Kristen Kluska	Maintained	Overweight	$112
—	Cantor Fitzgerald	Kristen Kluska	Maintained	Overweight	$112
—	Cantor Fitzgerald	Kristen Kluska	Maintained	Overweight	$112
—	Cantor Fitzgerald	Kristen Kluska	Initiate	Overweight	$168
—	Oppenheimer	Jay Olson	Initiate	Outperform	$200
—	Piper Sandler	Edward Tenthoff	PT Raise	Overweight	$12→$20

Skye Bioscience Inc

Skye Bioscience (SKYE) Stock Price Target 2026

Latest Upgrades and Downgrades for Skye Bioscience Stock

Skye Bioscience (SKYE) Stock Price Target 2026

Latest Upgrades and Downgrades for Skye Bioscience Stock

Analyst Ratings News

Penny Stock Skye Bioscience Drug Combo With Wegovy Shows Over 22% Weight Loss After One Year

PRO
HC Wainwright & Co. Initiates Coverage On Skye Bioscience with Buy Rating, Announces Price Target of $20

Could This New Drug Be The Safer Way To Fight Obesity?

Skye Bioscience Advances Position In Competitive Obesity Market With Promising Data

PRO
Evercore ISI Group Initiates Coverage On Skye Bioscience with Outperform Rating, Announces Price Target of $10

PRO
JMP Securities Reiterates Market Outperform on Skye Bioscience, Maintains $15 Price Target

People Also Watch

People Also Watch

Analyst Ratings News

Penny Stock Skye Bioscience Drug Combo With Wegovy Shows Over 22% Weight Loss After One Year

PRO
HC Wainwright & Co. Initiates Coverage On Skye Bioscience with Buy Rating, Announces Price Target of $20

Could This New Drug Be The Safer Way To Fight Obesity?

Skye Bioscience Advances Position In Competitive Obesity Market With Promising Data

PRO
Evercore ISI Group Initiates Coverage On Skye Bioscience with Outperform Rating, Announces Price Target of $10

PRO
JMP Securities Reiterates Market Outperform on Skye Bioscience, Maintains $15 Price Target

Skye Bioscience Inc

Skye Bioscience (SKYE) Stock Price Target 2026

Latest Upgrades and Downgrades for Skye Bioscience Stock

Skye Bioscience (SKYE) Stock Price Target 2026

Latest Upgrades and Downgrades for Skye Bioscience Stock

Analyst Ratings News

Penny Stock Skye Bioscience Drug Combo With Wegovy Shows Over 22% Weight Loss After One Year

PROHC Wainwright & Co. Initiates Coverage On Skye Bioscience with Buy Rating, Announces Price Target of $20

Could This New Drug Be The Safer Way To Fight Obesity?

Skye Bioscience Advances Position In Competitive Obesity Market With Promising Data

PROEvercore ISI Group Initiates Coverage On Skye Bioscience with Outperform Rating, Announces Price Target of $10

PROJMP Securities Reiterates Market Outperform on Skye Bioscience, Maintains $15 Price Target

People Also Watch

People Also Watch

Analyst Ratings News

Penny Stock Skye Bioscience Drug Combo With Wegovy Shows Over 22% Weight Loss After One Year

PROHC Wainwright & Co. Initiates Coverage On Skye Bioscience with Buy Rating, Announces Price Target of $20

Could This New Drug Be The Safer Way To Fight Obesity?

Skye Bioscience Advances Position In Competitive Obesity Market With Promising Data

PROEvercore ISI Group Initiates Coverage On Skye Bioscience with Outperform Rating, Announces Price Target of $10

PROJMP Securities Reiterates Market Outperform on Skye Bioscience, Maintains $15 Price Target

PRO
HC Wainwright & Co. Initiates Coverage On Skye Bioscience with Buy Rating, Announces Price Target of $20

PRO
Evercore ISI Group Initiates Coverage On Skye Bioscience with Outperform Rating, Announces Price Target of $10

PRO
JMP Securities Reiterates Market Outperform on Skye Bioscience, Maintains $15 Price Target

PRO
HC Wainwright & Co. Initiates Coverage On Skye Bioscience with Buy Rating, Announces Price Target of $20

PRO
Evercore ISI Group Initiates Coverage On Skye Bioscience with Outperform Rating, Announces Price Target of $10

PRO
JMP Securities Reiterates Market Outperform on Skye Bioscience, Maintains $15 Price Target